Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

3.08
-0.0400-1.28%
Volume:682.28K
Turnover:2.11M
Market Cap:256.90M
PE:-2.20
High:3.21
Open:3.15
Low:3.02
Close:3.12
52wk High:5.55
52wk Low:1.03
Shares:83.41M
Float Shares:49.56M
Volume Ratio:1.01
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:22.46
PE(LYR):-2.40

Loading ...

NASDAQ Trade Halt Volatility Trading Pause at 12:27 Pm

Reuters
·
Aug 12

Pyxis Oncology Inc Expected to Post a Loss of 35 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Pyxis Oncology Initiated at Overweight by Wells Fargo

Dow Jones
·
Aug 03

Wells Fargo Initiates Pyxis Oncology at Overweight With $12 Price Target

MT Newswires Live
·
Aug 03

Pyxis Oncology Files Form 3 Beneficial Ownership Statement for Gordonmd Global Investments LP

Reuters
·
Jul 11

Analysts’ Top Healthcare Picks: Pyxis Oncology (PYXS), Pfizer (PFE)

TIPRANKS
·
Jul 03

Pyxis Oncology Director Jakob Dupont Disposes of 35,000 Common Shares Worth $107,100

Reuters
·
Jul 03

Pyxis Oncology Prices Unregistered Private Placement at USD 50 Million

Reuters
·
Jul 03

Pyxis Oncology is Maintained at Outperform by Leerink Partners

Dow Jones
·
Jul 02

Pyxis Oncology Posts Corporate Deck Outlining Strategy to Build Differentiated Antibody-drug Conjugate Company Around MICVO Program in Head and Neck Cancer

Reuters
·
Jun 30

Pyxis Oncology announces up to $114M private placement

TIPRANKS
·
Jun 30

Guggenheim Sticks to Its Buy Rating for Pyxis Oncology (PYXS)

TIPRANKS
·
Jun 30

Pyxis Oncology Prices USD 50 Million Private Placement at USD 2.55 a Share

Reuters
·
Jun 30

Pyxis Oncology - Expects Updated Phase 1 Monotherapy Data in Fall 2026 and Phase 1/2 Data in Q4 2026

THOMSON REUTERS
·
Jun 30

Pyxis Oncology - Sells 19.6 Mln Shares at $2.55 Each with Warrants at $3.29 Exercise Price

THOMSON REUTERS
·
Jun 30

Pyxis Oncology: Financing Led by Bvf Partners L.p. with Participation from Gordonmd Global Investments, Rtw Investments, & Coastlands Capital

THOMSON REUTERS
·
Jun 30

Pyxis Oncology - Upfront Proceeds Expected to Extend Cash Runway into Q2 2027

THOMSON REUTERS
·
Jun 30

Pyxis Oncology Announces up to $114 Million Private Placement Financing to Advance Micvo Through Key Clinical Milestones

THOMSON REUTERS
·
Jun 30

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

GlobeNewswire
·
Jun 30

Penny Stocks To Watch For Growth In June 2026

Simply Wall St.
·
Jun 19